
Worldwide Market for Clinical Laboratory Services, 10th Edition
Description
Worldwide Market for Clinical Laboratory Services, 10th Edition provides a definitive analysis of the global clinical lab services industry, offering critical insights into market size, growth drivers, testing types in demand, and competitive positioning from 2024 to 2029. This report is a key resource for stakeholders seeking to understand diagnostic service dynamics in the wake of COVID-19’s transition to endemic status.
Why This Report is Essential for IVD Manufacturers
This annual review by Kalorama Information is indispensable for IVD manufacturers. Clinical laboratories are the core of the in vitro diagnostics (IVD) market, delivering essential insights for diagnosis, monitoring, and treatment across a wide range of conditions—from genetic and infectious diseases to chronic illnesses and oncology. With 70–80% of clinical diagnoses informed by lab tests, these services remain integral to modern healthcare delivery.
Market Opportunity in Lab Services: Now in Its 10th Edition
The 10th edition of this report offers an in-depth assessment of the clinical laboratory landscape, highlighting developments that are shaping global testing demand. From historical market trends to current and forecasted data, the report helps companies benchmark performance and prepare for future shifts.
Key Features of the Report
The report includes a comprehensive competitive review of top clinical laboratory service providers, detailing their market strategies, regional strengths, and adjustments in response to shifting healthcare delivery models and reimbursement structures.
Data and Forecasting
Each edition of the report is revised to reflect new industry developments, including pricing pressures, reimbursement reform, consolidation trends, and the continued impact of COVID-19. It also considers operational shifts such as increased reliance on home-based and outpatient care settings, driving new demand patterns for diagnostic services.
Exclusions
The report excludes revenues from clinical trial testing, veterinary labs, environmental testing, and ancillary services such as specimen collection and transportation.
Please Note: Single user allows for up to 3 users for this report.
Why This Report is Essential for IVD Manufacturers
This annual review by Kalorama Information is indispensable for IVD manufacturers. Clinical laboratories are the core of the in vitro diagnostics (IVD) market, delivering essential insights for diagnosis, monitoring, and treatment across a wide range of conditions—from genetic and infectious diseases to chronic illnesses and oncology. With 70–80% of clinical diagnoses informed by lab tests, these services remain integral to modern healthcare delivery.
Market Opportunity in Lab Services: Now in Its 10th Edition
The 10th edition of this report offers an in-depth assessment of the clinical laboratory landscape, highlighting developments that are shaping global testing demand. From historical market trends to current and forecasted data, the report helps companies benchmark performance and prepare for future shifts.
Key Features of the Report
- Industry Overview: Presents a detailed exploration of the clinical laboratory sector, including its historical roots, evolving role in healthcare, and the growing reliance on outpatient and remote testing.
- Influential Statistics: Analyzes demographic shifts, disease incidence trends, life expectancy, and the broader healthcare environment impacting the clinical lab industry.
- Global Focus: Regional breakdowns include:
- North America (United States, Canada)
- EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
- Asia Pacific (Japan, China, India, South Korea, Australia)
- Latin America (Brazil, Mexico)
- Essential and Routine Testing: Clinical chemistry, hematology, coagulation, and endocrinology
- Immunology and Microbiology Testing
- Cytology and Histology Testing
- Genetic Testing
- Toxicology Testing (Drugs of Abuse)
- COVID-19 Testing
- Independent and Reference Laboratories
- Hospital-based Laboratories
- Clinic-based Laboratories
The report includes a comprehensive competitive review of top clinical laboratory service providers, detailing their market strategies, regional strengths, and adjustments in response to shifting healthcare delivery models and reimbursement structures.
Data and Forecasting
- Base Year: 2024
- Historical Data: 2019–2024
- Forecast Period: 2025–2029
- CAGRs: Provided for all major segments
- Market Level: Service provider/manufacturer level revenues
Each edition of the report is revised to reflect new industry developments, including pricing pressures, reimbursement reform, consolidation trends, and the continued impact of COVID-19. It also considers operational shifts such as increased reliance on home-based and outpatient care settings, driving new demand patterns for diagnostic services.
Exclusions
The report excludes revenues from clinical trial testing, veterinary labs, environmental testing, and ancillary services such as specimen collection and transportation.
Please Note: Single user allows for up to 3 users for this report.
Table of Contents
270 Pages
- About Kalorama Information
- Industry at a Glance
- Scope and Methodology
- Global Market Overview
- Key Issues and Trends Affecting the Market
- Leading Market Participants
- Clinical Laboratory Description
- Number of Laboratory Health Workers by Country
- The Largest Clinical Laboratory Market: The United States
- Laboratory Developed Test Regulations
- Payers and Reimbursement
- Transparency in Pricing
- Direct-to-Consumer Testing
- Expanding Cancer Test Utilization and Technologies
- The Role of Information Technology
- Industry Drivers
- Test and Services Overview
- Clinical Chemistry - Routine and Essential Testing
- Immunology and Microbiology
- Cytology and Histology Testing
- Genetic Testing
- Toxicology Testing
- Clinical Laboratory Market: Provider Overview
- Hospitals and Acute Care Providers
- Physicians and Outpatient Care Providers
- Independent Laboratory Providers
- Overview
- United States
- Canada
- Overview
- Key Markets
- Overview
- Key Countries
- Overview
- Key Countries
- Global Competitor Summary
- U.S. Competitive Analysis
- Select Company Profiles
- ARUP Laboratories
- BioReference Health - An OPKO Health Subsidiary
- DaVita
- Eurofins Scientific SE
- Exact Sciences Corp.
- Guardant Health
- H.U. Group Holdings
- Laboratory Corporation of America
- Medicover AB
- Myriad Genetics, Inc.
- Natera
- Quest Diagnostics, Inc.
- Siemens Healthineers
- Sonic Healthcare Limited
- SYNLAB International GmbH
- Unilabs
- Global Market Overview
- Regional Overview
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.